Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Boston Scientific has notched billions of goodwill write-offs related to its $28 billion acquisition of Guidant Corp., a sign that the medical device titan may have overpaid for the deal.
The FDA orders St. Jude Medical to conduct a 3-year postmarket review on its recalled Riata and Riata ST defibrillator leads as well as 3 additional sets of leads not associated with the recall.
MassDevice.com’s Big 100 database reveals the medical device companies that post the highest net profit margins – and the lowest.